Jill Connelly / Bloomberg via Getty Images
Pfizer and BioNTech are officially asking the Biden government to approve the use of their COVID-19 vaccine for children ages 5-11.
Pfizer tweeted on Thursday that the companies had filed their formal application for emergency approval of the vaccine with the Food and Drug Administration.
“As new cases of children in the US remain at a high level, this application is an important step in our ongoing efforts against # COVID19,” said the pharmaceutical giant.
The filing is the latest move in an effort to expand the use of the vaccine to younger children, a process that is being closely watched by many concerned parents as the new school year begins.
The Pfizer BioNTech vaccine has full FDA approval for people aged 16 and over, and people between the ages of 12 and 15 can get the vaccine under the current emergency clearance.
Last month, Pfizer and BioNTech presented data to the FDA showing that their vaccine produced “robust” antibody responses and had “favorable” safety results in children ages 5-11.